Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
48Hour Discovery logo — Advancing Peptide Drug Development

48Hour Discovery

Advancing Peptide Drug Development

Founded 2017 Canada Edmonton, Canada 13 employees Total: $1.55M Biotechnology

General Information

Company Name 48Hour Discovery
Founded Year 2017
Location Canada Edmonton, Canada
Employees 13
Industries Biotechnology
Business Model B2B, Platform, SaaS
Revenue Model Licensing, Project Based, Service Fee
Social

BounceWatch is an independent company data service, not affiliated with 48Hour Discovery. To contact 48Hour Discovery, visit 48hourdiscovery.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does 48Hour Discovery compare?

A PDF of 48Hour Discovery and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting 48Hour Discovery soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About 48Hour Discovery

48Hour Discovery, founded in 2017, is a pioneering company in the Biotechnology sector, dedicated to revolutionizing peptide-based drug discovery. Embracing their slogan, "Advancing Peptide Drug Development," the company is streamlining the process of developing new therapies. Their cutting-edge platform focuses on reducing the cost, time, and risk by employing an innovative target screening strategy, swiftly identifying the most promising drug leads.

Recently, 48Hour Discovery secured a $840.00K Debt Financing investment, reflecting increasing confidence in their potential. This financing, dated 01 January 2025, marks a significant milestone in the company’s growth trajectory, highlighting both their technological prowess and investment appeal. With no specified headquarters and unnamed investors, 48Hour Discovery maintains an enigmatic presence in the biotech landscape, drawing interest through their promising advancements.

Business keywords: Peptide Drug Discovery, Target Screening Strategy, Drug Lead Identification, Peptide-derived Molecules, Genetically-Encoded Peptides, Chemically Modified Peptides, Peptide-based Therapies, Drug Development Innovation, Rapid Ligand Identification, Cost-effective Drug Development, Risk Mitigation in Drug Discovery, Customizable Peptide Libraries, Flexible Pricing Models, Royalty-free Results, Biotechnology Platform

Services & Products

Peptide Discovery
Drug Lead Advancement
Customization in Drug Discovery
Synthesis, Validation, and Optimization of Peptides
Protein and Cell-based Screening

Target Customers

Emerging Startups Global Pharmaceutical Companies Clinical-stage Radiopharmaceutical Firms

Funding Rounds & Investors (4)

View All
Funding Stage Amount Investors Lead Investors Date
Debt Financing $840.00K -
01 Jan 2025
Grant $190.00K -
01 Apr 2019
Grant $20.00K -
01 Oct 2018
Spinout $500.00K -
01 Feb 2017

48Hour Discovery Alternatives & Competitors

View All Alternatives
48Hour Discovery vs
PepLib
PepLib China

Rethink Peptide Drug Discovery: Universal-Exact-Diverse

Series A
6 employees
Biotechnology, Health Care
48Hour Discovery vs
Orbit Discovery
Orbit Discovery United Kingdom

Delivering Peptide Enabled Drug Discovery Solutions

Seed
31 employees
Biotechnology, Health Care
48Hour Discovery vs
Design Pharmaceuticals Inc.
Design Pharmaceuticals Inc. United States

Boundless GPCR drug discovery

Seed
3 employees
Biotechnology, Health Care
View all alternatives

FAQ About 48Hour Discovery

Advancing Peptide Drug Development
48Hour Discovery was founded in 2017.
48Hour Discovery is headquartered in Edmonton, Canada.
48Hour Discovery operates in Biotechnology. Its work centres on Peptide Drug Discovery, Target Screening Strategy, Drug Lead Identification and Peptide-derived Molecules. Its customers include Emerging Startups, Global Pharmaceutical Companies and Clinical-stage Radiopharmaceutical Firms.
48Hour Discovery has a B2B, Platform and SaaS business model. Its revenue comes from Licensing, Project Based and Service Fee.
48Hour Discovery has approximately 13 employees.
48Hour Discovery has completed 4 funding rounds, raising a total of $1.55M.
48Hour Discovery offers: Peptide Discovery, Drug Lead Advancement, Customization in Drug Discovery, Synthesis, Validation, and Optimization of Peptides, Protein and Cell-based Screening.
Top alternatives and competitors to 48Hour Discovery include PepLib , Orbit Discovery, Design Pharmaceuticals Inc., Deargen, Thelial Technologies. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
48Hour Discovery and PepLib are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for 48Hour Discovery, https://bouncewatch.com/company/48hour-discovery, updated 15 June 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes